SCHEMBL7590064

SCHEMBL7590064

CCOC(=O)c1nc2cccc(F)c2c(F)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 1/20 0.43
GLP1R P43220 1/20 0.41
NPSR1 Q6W5P4 3/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM5B Q9UGL1 1/20 0.39
TARBP2 Q15633 1/20 0.39
PARP1 P09874 1/20 0.39
ALOX15 P16050 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2026690 0.81 CYP1A2 (0.44) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL10157247 0.80 SMN1; SMN2 (0.49) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2019580 0.75 MAPT (0.49) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL2021969 0.75 CYP1A2 (0.46) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2718914 0.74 KMT2A (0.50) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL2024770 0.74 CYP1A2 (0.45) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL12877431 0.73 SMN1; SMN2 (0.50) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL537851 0.73 PARP1 (0.46) PARP1
SCHEMBL30682026 0.72 GLP1R (0.53) ALDH1A1KDM4ETSHRHSD17B10CYP1A2
SCHEMBL26617497 0.72 GLP1R (0.53) ALDH1A1KDM4ETSHRHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0538100-B1 Process for the preparation of fluoro-quinolin-3-carboxylic acid derivatives AVENTIS PHARMA SA (FR) 2002-02-06 EP disclosed
EP-0641341-B1 METHOD FOR PREPARING BENZO [b]NAPHTHYRIDINES RHONE POULENC RORER SA (FR) 2000-03-01 EP disclosed
EP-0693060-B1 METHOD OF PREPARATION OF 6-FLUORO-2-HALOGEN QUINOLINE RHONE POULENC RORER SA (FR) 1998-03-18 EP disclosed
EP-0693060-A1 METHOD OF PREPARATION OF 6-FLUORO-2-HALOGEN QUINOLINE Aventis Pharma S.A. (FR) 1996-01-24 EP disclosed
EP-0641341-A1 METHOD FOR PREPARING BENZO b]NAPHTHYRIDINES LABORATOIRE ROGER BELLON (FR) 1995-03-08 EP disclosed
WO-1994024113-A1 METHOD OF PREPARATION OF 6-FLUORO-2-HALOGEN QUINOLINE RHONE-POULENC RORER S.A. (FR) 1994-10-27 WO disclosed
EP-0607329-A1 NEW DERIVATIVES OF FLUORO-QUINOLINE CARBOXYLIC-3 ACID AND PREPARATION THEREOF LABORATOIRE ROGER BELLON (FR) 1994-07-27 EP disclosed
EP-0538100-A1 New fluoro-quinolin-3-carboxylic acid derivatives and their preparation LABORATOIRE ROGER BELLON (FR) 1993-04-21 EP disclosed
EP-0538101-A1 Process for the preparation of benzo(b)naphthyridines LABORATOIRE ROGER BELLON (FR) 1993-04-21 EP disclosed
WO-1993007127-A1 NEW DERIVATIVES OF FLUORO-QUINOLINE CARBOXYLIC-3 ACID AND PREPARATION THEREOF LABORATOIRE ROGER BELLON (FR) 1993-04-15 WO disclosed
WO-1993007145-A1 METHOD FOR PREPARING BENZO[b]NAPHTHYRIDINES LABORATOIRE ROGER BELLON (FR) 1993-04-15 WO disclosed